|
BL-M14D1 Clinical Trials
3 actively recruiting trials across 1 location
▲ +1 trial since August 2026
Pipeline
Phase 1: 2Phase 2: 1
Top Sponsors
- Sichuan Baili Pharmaceutical Co., Ltd.2
- SystImmune Inc.1
Indications
- Lung Cancer3
- Cancer3
- Metastatic Large Cell Neuroendocrine Carcinoma of the Lung1
- Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine1
- Locally Advanced Neuroendocrine Prostate Cancer1
Other2 trials
Huntsville, Alabama1 trial
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Clearview Cancer Institute
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.